Viewing Study NCT05429294


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-29 @ 3:07 AM
Study NCT ID: NCT05429294
Status: UNKNOWN
Last Update Posted: 2022-06-23
First Post: 2022-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module